27 research outputs found

    Cervicale spondylodiscitis veroorzaakt door Streptococcus agalactiae

    Get PDF
    The medical history of a previously perfectly healthy 45-year-old male patient with acute cervical pain is presented. From cultures of the discus C5-C6, Streptococcus agalactiae was isolated. The patient was treated with penicillin and clindamycin, and recovered quickly. Streptococcus agalactiae is reported as a cause of invasive infections in neonati and pregnant women, but in recent years, an increasing number of infections have been reported in adults. One of the reasons may be that, nowadays, there are more patients with immunocompromising diseases, such as diabetes mellitus and malignancies. Another factor may be an increasing virulence of Streptococcus agalactiae, caused by a myriad of virulence factors. Investigation of these factors may help to prevent a further increase of invasive infections with Streptococcus agalactiae by vaccination and antibiotherapy

    Treatment of skeletal muscle injury: a review

    Get PDF
    Skeletal muscle injuries are the most common sports-related injuries and present a challenge in primary care and sports medicine. Most types of muscle injuries would follow three stages: the acute inflammatory and degenerative phase, the repair phase and the remodeling phase. Present conservative treatment includes RICE (rest, ice, compression, elevation), nonsteroidal anti-inflammatory drugs (NSAIDs) and physical therapy. However, if use improper, NSAIDs may suppress an essential inflammatory phase in the healing of injured skeletal muscle. Furthermore, it remains controversial whether or not they have adverse effects on the healing process or on the tensile strength. However, several growth factors might promote the regeneration of injured skeletal muscle, many novel treatments have involved on enhancing complete functional recovery. Exogenous growth factors have been shown to regulate satellite cell proliferation, differentiation and fusion in myotubes in vivo and in vitro, TGF-β1 antagonists behave as inhibitors of TGF-β1. They prevent collagen deposition and block formation of muscle fibrosis, so that a complete functional recovery can be achieved
    corecore